ChenGuang Biotech Group Co., Ltd.

XSEC:300138 Stock Report

Market Cap: CN¥4.3b

ChenGuang Biotech Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Qingguo Lu

Chief executive officer

CN¥2.1m

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership21.3%
Management average tenureno data
Board average tenure1.6yrs

Recent management updates

Recent updates

CEO

Qingguo Lu (65 yo)

no data

Tenure

CN¥2,118,500

Compensation

Mr. Qingguo Lu is Chairman & GM of ChenGuang Biotech Group Co., Ltd.

Board Members

NamePositionTenureCompensationOwnership
Qingguo Lu
Chairman & GMno dataCN¥2.12m21.3%
CN¥ 905.5m
Jing Zhou
CFO, Secretary of the Board & Director5.7yrsCN¥678.00k1.71%
CN¥ 72.8m
Tao Zhao
Employee Representative Supervisorno datano data0.011%
CN¥ 465.9k
Ying Lu
Non-Independent Director1.6yrsCN¥3.97mno data
Wei Gao
Supervisory Board Chairmanno dataCN¥652.40k0.015%
CN¥ 653.0k
Shaohua Wang
Non Employee Representative Supervisorno datano datano data
Xiaofeng Dai
Independent Director1.6yrsCN¥49.00kno data
Hong Niu
Independent Director1.6yrsCN¥49.00kno data
Liangqiu Li
Independent Director1.6yrsCN¥49.00kno data

1.6yrs

Average Tenure

44yo

Average Age

Experienced Board: 300138's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 12:54
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ChenGuang Biotech Group Co., Ltd. is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Siyuan DongChangjiang Securities Co. LTD.
Wendan WangChina International Capital Corporation Limited
Guang Yao ChenFounder Securities Co., Ltd.